Heisterberg J. How Should Synthetic Follow-Ons of Biological Products Be Regulated? What Are the Implications for Automatic Substitution?. Acta Pharm Hung [Internet]. 2021Nov.15 [cited 2026Aug.21];91(3-4):108-9. Available from: https://www.aph-hsps.hu/acta/index.php/aph/article/view/60